PECAM1 and neoplasm: Compared to control tumors, which showed increased numbers of CD31+ blood vessels at large tumor volumes, significantly fewer vessels were evident in tumors exposed to sunitinib at tumor volumes of 300 mm3 and vessel density did not increase with larger tumor sizes but, in fact, decreased (Figure 2a,b), indicating response to sunitinib.